Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

310 Views

Poster Session: COVID-19: Complications, Coinfections and Clinical Outcomes

304 - Viral resistance analysis in the COMET-PEAK study: sotrovimab treatment in participants with mild-to-moderate COVID-19

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

PY

Phillip J Yates, PhD

GlaxoSmithKline
Stevenage, England, United Kingdom
JM

Jennifer Moore, MD

GlaxoSmithKline
Brentford, England, United Kingdom
JH

Jennifer Han, MD

Sr. Clinical Development Director, Clinical Sciences (Infectious Diseases and Virology)
GlaxoSmithKline
Collegeville, Pennsylvania, United States
AS

Andrew Skingsley, MD

GlaxoSmithKline
Brentford, England, United Kingdom
GS

Gretja Schnell, PhD

Vir Biotechnology, Inc.
San Francisco, California, United States
AC

Andrea L. Cathcart, PhD

Vir Biotechnology, Inc.
San Francisco, California, United States
MA

Melissa Aldinger, PharmD

Vir Biotechnology, Inc.
San Francisco, California, United States
AP

Amanda Peppercorn, MD

GlaxoSmithKline
Cambridge, Massachusetts, United States

Presenting Author(s)

JW

Jill Walker, PhD

Group Leader, Clinical Virology
GlaxoSmithKline
Cambridge, Massachusetts, United States